| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine, namely to pharmaceutical industry. Complex of carbamazepine-cyclodextrin inclusion is obtained by mixing modified cyclodextrin and carbamazepine in physiologically acceptable liquid. Modified cyclodextrins include 2-hydroxylpropyl-bata-cyclodextrin and sulfonylcyclodextrins. Physiologicallyt acceptable liquid includes sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), physiological salt solution and analogous liquids, suitable for parenteral introduction. ^ EFFECT: obtaining complex of carbamazepine-cyclodextrin inclusion which can be applied for parenteral introduction of carbamazepine. ^ 24 cl, 9 tbl, 9 ex, 7 dwg |
